Document Detail

Energy minimization methods applied to riboswitches: a perspective and challenges.
MedLine Citation:
PMID:  20061789     Owner:  NLM     Status:  MEDLINE    
Energy minimization methods for RNA secondary structure prediction have been used extensively for studying a variety of biological systems. Here, we demonstrate their applicability in riboswitch studies, exemplified in both the expression platform and aptamer domains. In the expression platform domain, energy minimization methods can be used to predict in silico a unique point mutation positioned in the non-conserved region of the TPP riboswitch that will transform it from a termination to an anti-termination state, thus backing the prediction experimentally. Furthermore, a successive prediction can be made for a compensatory mutation that is positioned over half the sequence length of the riboswitch from the original mutation and that completely overturns the anti-termination effect of the original mutation. This approach can be used to computationally predict rational modifications in riboswitches for both research and practical applications. In the aptamer domain, energy minimization methods can be used when attempting to detect a novel purine riboswitch in eukaryotes based on the consensus sequence and structure of the bacterial guanine binding aptamer. In the process, some interesting candidates are identified, and although they are attractive enough to be tested experimentally, they are not detectable by sequence based methods alone. These brief examples represent the important lessons to be learned as to the strengths and limitations of energy minimization methods. In light of our growing knowledge in the energy minimization field, future challenges can be advanced for the rational design of known riboswitches and the detection of novel riboswitches. Unlike analyses of specific cases, it is stressed that all the results described here are predictive in scope with direct applicability and an attempt to validate the predictions experimentally.
Danny Barash; Idan Gabdank
Related Documents :
21463859 - Automated detection of the osseous acetabular rim using three-dimensional models of the...
17266259 - Quantifying the hydrophobic effect. 3. a computer simulation-molecular-thermodynamic mo...
21219909 - Modeling of biological doses and mechanical effects on bone transduction.
19809129 - Metabolic models to investigate energy limited anaerobic ecosystems.
25286839 - Continuous mutual improvement of macromolecular structure models in the pdb and of x-ra...
20414699 - Rapid prediction of solvation free energy. 3. application to the sampl2 challenge.
23026309 - Partial acceptor photobleaching-based quantitative fret method completely overcoming em...
6383799 - Inhalation exposure methodology.
10697759 - Formulation optimization technique based on artificial neural network in salbutamol sul...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-01-16
Journal Detail:
Title:  RNA biology     Volume:  7     ISSN:  1555-8584     ISO Abbreviation:  RNA Biol     Publication Date:    2010 Jan-Feb
Date Detail:
Created Date:  2010-07-27     Completed Date:  2010-11-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101235328     Medline TA:  RNA Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  90-7     Citation Subset:  IM    
Department of Computer Science, Ben-Gurion University, Beer-Sheva, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Base Sequence
Computational Biology / methods*
Molecular Sequence Data
Nucleic Acid Conformation
Point Mutation / genetics
Regulatory Sequences, Ribonucleic Acid / genetics*
Thiamine Pyrophosphate / metabolism
Reg. No./Substance:
0/Regulatory Sequences, Ribonucleic Acid; 154-87-0/Thiamine Pyrophosphate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder c...
Next Document:  Recombinant protein vaccines against the asexual blood-stages of Plasmodium falciparum.